01 Jul Cost-effectiveness of rapid susceptibility testing against second-line drugs for tuberculosis.
Posted at 00:00h
in
Authored by: Dowdy David, van’t Hoog A. H., Shah M, Cobelens F.
In: Int J Tuberc Lung Dis., 2014
http://www.ncbi.nlm.nih.gov/pubmed/24903933
http://www.ingentaconnect.com/content/iuatld/ijtld/2014/00000018/00000006/art00006?token=004f16c7f9f6b2405847447b496e2f2d40386f3b2065477e33757e6f4f2858592f3f3b5778bdf65